Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q0VCN0

Entry ID Method Resolution Chain Position Source
AF-Q0VCN0-F1 Predicted AlphaFoldDB

45 variants for Q0VCN0

Variant ID(s) Position Change Description Diseaes Association Provenance
rs470943670 9 V>G No EVA
rs458696852 10 G>C No EVA
rs458758934 14 S>Y No EVA
rs476170780 25 T>P No EVA
rs454486209 26 E>* No EVA
rs442430186 28 D>A No EVA
rs472101374 34 D>A No EVA
rs454215579 37 D>G No EVA
rs432533134 38 N>T No EVA
rs456747580 60 F>S No EVA
rs438003010 61 T>A No EVA
rs438003010 61 T>P No EVA
rs467698359 63 C>G No EVA
rs467698359 63 C>R No EVA
rs449298936 66 Y>F No EVA
rs479150197 68 T>P No EVA
rs477574367 136 V>G No EVA
rs465750993 147 F>L No EVA
rs447394418 148 W>* No EVA
rs447394418 148 W>L No EVA
rs439406600 159 G>R No EVA
rs475565397 163 Q>H No EVA
rs720526086 165 V>I No EVA
rs463660461 167 T>P No EVA
rs460823520 170 T>A No EVA
rs460229080 175 L>R No EVA
rs439003692 179 W>R No EVA
rs471977008 180 V>D No EVA
rs471977008 180 V>G No EVA
rs444793301 183 G>D No EVA
rs455766891 185 T>A No EVA
rs433951749 185 T>K No EVA
rs473517420 194 I>L No EVA
rs432180724 199 L>R No EVA
rs464947746 200 A>P No EVA
rs437895562 202 E>G No EVA
rs456170478 202 E>K No EVA
rs450579924 208 A>G No EVA
rs435778553 209 V>G No EVA
rs458354089 231 F>L No EVA
rs446028047 232 E>D No EVA
rs481988079 233 S>Y No EVA
rs463695818 234 N>T No EVA
rs109427983 240 I>M No EVA
rs440172418 253 S>A No EVA

No associated diseases with Q0VCN0

1 regional properties for Q0VCN0

Type Name Position InterPro Accession
conserved_site Claudin, conserved site 48 - 63 IPR017974

Functions

Description
EC Number
Subcellular Localization
  • Cell junction, tight junction
  • Cell membrane ; Multi-pass membrane protein
  • Localizes to tight junctions in epithelial cells
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
bicellular tight junction An occluding cell-cell junction that is composed of a branching network of sealing strands that completely encircles the apical end of each cell in an epithelial sheet; the outer leaflets of the two interacting plasma membranes are seen to be tightly apposed where sealing strands are present. Each sealing strand is composed of a long row of transmembrane adhesion proteins embedded in each of the two interacting plasma membranes.
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

1 GO annotations of molecular function

Name Definition
structural molecule activity The action of a molecule that contributes to the structural integrity of a complex or its assembly within or outside a cell.

8 GO annotations of biological process

Name Definition
bicellular tight junction assembly The aggregation, arrangement and bonding together of a set of components to form a tight junction, an occluding cell-cell junction that is composed of a branching network of sealing strands that completely encircles the apical end of each cell in an epithelial sheet.
cell adhesion The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.
digestive tract development The process whose specific outcome is the progression of the digestive tract over time, from its formation to the mature structure. The digestive tract is the anatomical structure through which food passes and is processed.
negative regulation of bone resorption Any process that stops, prevents, or reduces the frequency, rate or extent of bone resorption.
negative regulation of osteoclast development Any process that stops, prevents or reduces the frequency, rate or extent of osteoclast development.
negative regulation of protein localization to nucleus Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to nucleus.
protein localization to nucleus A process in which a protein transports or maintains the localization of another protein to the nucleus.
TNFSF11-mediated signaling pathway The series of molecular signals initiated by the binding of tumor necrosis factor ligand superfamily member 11 (TNFSF11) to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription.

3 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P56856 CLDN18 Claudin-18 Homo sapiens (Human) PR
P56857 Cldn18 Claudin-18 Mus musculus (Mouse) PR
Q9NGJ7 clc-5 Clc-like protein 5 Caenorhabditis elegans PR
10 20 30 40 50 60
MSTTRCQVVG FLLSILGLAG CIVATEMDMW STQDLYDNPV TAVFQYEGLW RSCVQQSSGF
70 80 90 100 110 120
TECRPYLTIL GLPAMLQAVR ALMIVGIVLS VIGLLVAIFA LKCIRMGNMD DSAKAKMTLT
130 140 150 160 170 180
SGIMFIIAGL CAIAGVSVFA NMLVTNFWMS TASMFTSMGG MVQTVQTRYT FGAALFVGWV
190 200 210 220 230 240
AGGLTLIGGV LMCIACRGLA PEETNYKAVS YHASGHNVAY RPGGFKASSG FESNTRNKKI
250 260
YDGGARTEDE GQSPPSKYDY V